Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SPHK1 | Q9NYA1 | 6/20 | 0.46 |
| ▸ | EPHX1 | P07099 | 8/20 | 0.41 |
| ▸ | NAAA | Q02083 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | ACHE | P22303 | 1/20 | 0.39 |
| ▸ | MMP2 | P08253 | 1/20 | 0.39 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8396618 | 0.93 | SPHK1 (0.55) | SPHK1EPHX1NAAAEPHX2 | |
| SCHEMBL8395145 | 0.93 | SPHK1 (0.55) | SPHK1EPHX1NAAAEPHX2 | |
| SCHEMBL8395995 | 0.93 | SPHK1 (0.55) | SPHK1EPHX1NAAAEPHX2 | |
| SCHEMBL24654085 | 0.78 | ACHE (0.46) | SPHK1EPHX1ACHE | |
| SCHEMBL11395604 | 0.77 | CETP (0.47) | SPHK1EPHX1NAAAACHEMMP2 | |
| SCHEMBL29306660 | 0.75 | SPHK1 (0.50) | SPHK1EPHX1NAAAEPHX2 | |
| SCHEMBL23133081 | 0.73 | SPHK1 (0.47) | SPHK1EPHX1ACHEMMP2 | |
| SCHEMBL4678180 | 0.71 | SPHK1 (0.54) | SPHK1EPHX1NAAA | |
| SCHEMBL18434965 | 0.70 | SPHK1 (0.45) | SPHK1EPHX1ACHEMMP2 | |
| Cyclohexane SCHEMBL28879540 | 0.70 | EPHX1 (0.52) | EPHX1NAAAACHEMMP2EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5864043-A | CARDIOVASCULAR DISORDERS AND ANGIOTENSIN ANTAGONIST | KARL THOMAE GMBH (DE) | 1999-01-26 | — | — | US | disclosed |
| US-5614519-A | (1-(2,3 or 4-N-morpholinoalkyl)-imidazol-4-yl)-benizimidazol-1-yl-methyl]-biphenyls useful as angiotensin-II antagonists | KARL THOMAE GMBH (DE) | 1997-03-25 | — | — | US | disclosed |
| US-5602127-A | ADMINISTERING TO TREAT HYPERTENSION | KARL THOMAE GMBH (DE) | 1997-02-11 | — | — | US | disclosed |
| US-5594003-A | HYPOTENSIVE AGENTS | DR. KARL THOMAE GMBH (DE) | 1997-01-14 | — | — | US | disclosed |
| US-5591762-A | HYPOTENSIVE AGENTS | DR. KARL THOMAE GMBH (DE) | 1997-01-07 | — | — | US | disclosed |
| US-5541229-A | ANGIOITENSIN II ANTAGONIST AS HYPOTENSIVE AGENTS, ANTIISCHEMIC AGENTS AND CARDIOVASCULAR DISORDERS | DR. KARL THOMAE GMBH (DE) | 1996-07-30 | — | — | US | disclosed |
| US-5459147-A | Angeotensin-antagonistic effects; hypotensive, antiischemic, and antidiabetic agents, treating glaucoma | DR. KARL THOMAE GMBH (DE) | 1995-10-17 | — | — | US | disclosed |